| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Gang Liu | Q47982882 |
| P2093 | author name string | Victor J Thannickal | |
| Na Xie | |||
| Huachun Cui | |||
| P2860 | cites work | Emerging role of MicroRNAs and long noncoding RNAs in respiratory disease. | Q38228031 |
| Therapeutic targeting of microRNAs: current status and future challenges | Q38228101 | ||
| The genetic signatures of noncoding RNAs | Q21092463 | ||
| Phosphatidylinositol-3-Kinase/Akt regulates bleomycin-induced fibroblast proliferation and collagen production | Q23924071 | ||
| Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT | Q24313396 | ||
| HMGA2 and Smads co-regulate SNAIL1 expression during induction of epithelial-to-mesenchymal transition | Q24318681 | ||
| An RNA-dependent RNA polymerase formed by TERT and the RMRP RNA | Q24336971 | ||
| Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs | Q24537328 | ||
| Inhibition and role of let-7d in idiopathic pulmonary fibrosis | Q24599153 | ||
| MicroRNA-210: a unique and pleiotropic hypoxamir | Q24601095 | ||
| Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis | Q24607308 | ||
| The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression | Q24608592 | ||
| MENepsilon/beta noncoding RNAs are essential for structural integrity of nuclear paraspeckles | Q24646100 | ||
| miRiad roles for the miR-17-92 cluster in development and disease | Q24646970 | ||
| Cellular and molecular mechanisms of fibrosis | Q24648892 | ||
| Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA | Q24655224 | ||
| Cellular mechanisms of tissue fibrosis. 7. New insights into the cellular mechanisms of pulmonary fibrosis | Q27003892 | ||
| Pulmonary fibrosis: patterns and perpetrators | Q27694249 | ||
| Reviews and prospectives of signaling pathway analysis in idiopathic pulmonary fibrosis | Q38245567 | ||
| MicroRNA regulatory networks in idiopathic pulmonary fibrosis. | Q38306947 | ||
| Differential expression of long non-coding RNAs in bleomycin-induced lung fibrosis | Q38489550 | ||
| Serum miR-21 and miR-155 expression in idiopathic pulmonary fibrosis | Q39391772 | ||
| Discovery and validation of extracellular/circulating microRNAs during idiopathic pulmonary fibrosis disease progression | Q41336837 | ||
| Participation of miR-200 in pulmonary fibrosis | Q42157000 | ||
| Myeloid-specific disruption of tyrosine phosphatase Shp2 promotes alternative activation of macrophages and predisposes mice to pulmonary fibrosis | Q42201704 | ||
| Let-7d microRNA affects mesenchymal phenotypic properties of lung fibroblasts | Q42414811 | ||
| PI3K p110γ overexpression in idiopathic pulmonary fibrosis lung tissue and fibroblast cells: in vitro effects of its inhibition | Q42521125 | ||
| MicroRNA profiling implicates the insulin-like growth factor pathway in bleomycin-induced pulmonary fibrosis in mice | Q42590406 | ||
| miR-92a regulates TGF-β1-induced WISP1 expression in pulmonary fibrosis. | Q45956860 | ||
| MicroRNA-34a regulates cardiac ageing and function. | Q50320387 | ||
| MicroRNA-26a modulates transforming growth factor beta-1-induced proliferation in human fetal lung fibroblasts. | Q51679510 | ||
| Expression analysis of serum microRNAs in idiopathic pulmonary fibrosis. | Q54215913 | ||
| The long and short of RNAs | Q58883625 | ||
| Mnt: a novel Max-interacting protein and Myc antagonist | Q73725809 | ||
| Comparative expression profiling in pulmonary fibrosis suggests a role of hypoxia-inducible factor-1alpha in disease pathogenesis | Q80969911 | ||
| Circulating miRNAs might be promising biomarkers to reflect the dynamic pathological changes in smoking-related interstitial fibrosis | Q84562013 | ||
| MicroRNAs in lung diseases | Q84750021 | ||
| Mechanistic links between aging and lung fibrosis | Q37366137 | ||
| The complex eukaryotic transcriptome: unexpected pervasive transcription and novel small RNAs | Q37634306 | ||
| Fibrotic extracellular matrix activates a profibrotic positive feedback loop | Q37678004 | ||
| The pathogenesis of idiopathic pulmonary fibrosis. | Q37800756 | ||
| MicroRNAs in idiopathic pulmonary fibrosis. | Q37855082 | ||
| Notch signaling in lung development and disease | Q37991574 | ||
| Lipid-based carriers of microRNAs and intercellular communication | Q37993698 | ||
| Cellular players in lung fibrosis | Q38013135 | ||
| X-inactivation, imprinting, and long noncoding RNAs in health and disease | Q38090112 | ||
| Epithelial-mesenchymal transition in lung development and disease: does it exist and is it important? | Q38170969 | ||
| Origins and Mechanisms of miRNAs and siRNAs | Q27860822 | ||
| The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 | Q27860849 | ||
| MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
| MicroRNA expression profiles classify human cancers | Q28032481 | ||
| The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis | Q28240820 | ||
| The non-coding Air RNA is required for silencing autosomal imprinted genes | Q28504980 | ||
| Regulation of lung endoderm progenitor cell behavior by miR302/367 | Q28505583 | ||
| A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response | Q28592069 | ||
| microRNA functions | Q29547393 | ||
| MicroRNA biogenesis: coordinated cropping and dicing | Q29547496 | ||
| Treatment of HCV infection by targeting microRNA | Q29547712 | ||
| The Piwi-piRNA pathway provides an adaptive defense in the transposon arms race | Q29614715 | ||
| MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells | Q29616080 | ||
| Small non-coding RNAs in animal development | Q29616776 | ||
| c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism | Q29617213 | ||
| Molecular mechanisms of long noncoding RNAs | Q29618027 | ||
| Non-coding RNAs: regulators of disease | Q29618040 | ||
| RNA polymerase III transcribes human microRNAs | Q29618698 | ||
| New mechanisms of pulmonary fibrosis | Q30434264 | ||
| Integrated analyses identify the involvement of microRNA-26a in epithelial-mesenchymal transition during idiopathic pulmonary fibrosis | Q33720132 | ||
| The antifibrotic effects and mechanisms of microRNA-26a action in idiopathic pulmonary fibrosis | Q33724231 | ||
| MicroRNA-326 regulates profibrotic functions of transforming growth factor-β in pulmonary fibrosis | Q33799699 | ||
| Pathologic caveolin-1 regulation of PTEN in idiopathic pulmonary fibrosis | Q33882371 | ||
| Pathogenesis of idiopathic pulmonary fibrosis | Q33976506 | ||
| Development of microRNA therapeutics is coming of age. | Q33991443 | ||
| miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis | Q34044475 | ||
| miR-210 promotes IPF fibroblast proliferation in response to hypoxia | Q34062979 | ||
| Comprehensive microRNA analysis in bleomycin-induced pulmonary fibrosis identifies multiple sites of molecular regulation | Q34160776 | ||
| FoxO3a and disease progression | Q34161585 | ||
| MicroRNAs can generate thresholds in target gene expression | Q34209703 | ||
| miR-143 and miR-145 synergistically regulate ERBB3 to suppress cell proliferation and invasion in breast cancer | Q34273176 | ||
| Long noncoding RNAs regulate adipogenesis | Q34327368 | ||
| MicroRNA-96 inhibits FoxO3a function in IPF fibroblasts on type I collagen matrix | Q34356445 | ||
| Waste not, want not--transcript excess in multicellular eukaryotes | Q34413674 | ||
| Transcriptional noise and the fidelity of initiation by RNA polymerase II. | Q34574799 | ||
| Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells | Q34581070 | ||
| Cells infected with herpes simplex virus 1 export to uninfected cells exosomes containing STING, viral mRNAs, and microRNAs | Q34581114 | ||
| miR-199a-5p Is upregulated during fibrogenic response to tissue injury and mediates TGFbeta-induced lung fibroblast activation by targeting caveolin-1 | Q34607960 | ||
| FoxO3a (Forkhead Box O3a) deficiency protects Idiopathic Pulmonary Fibrosis (IPF) fibroblasts from type I polymerized collagen matrix-induced apoptosis via caveolin-1 (cav-1) and Fas. | Q34666156 | ||
| MicroRNA mimicry blocks pulmonary fibrosis | Q34880449 | ||
| Regulation of myofibroblast differentiation by miR-424 during epithelial-to-mesenchymal transition. | Q34979698 | ||
| The functional role of long non-coding RNA in human carcinomas | Q34995156 | ||
| The three R's of lung health and disease: repair, remodeling, and regeneration | Q35015756 | ||
| Nucleobase and ribose modifications control immunostimulation by a microRNA-122-mimetic RNA. | Q35048102 | ||
| MicroRNA-27b targets gremlin 1 to modulate fibrotic responses in pulmonary cells | Q35122146 | ||
| Fibrosis: ultimate and proximate causes | Q35140034 | ||
| miR-29 is a major regulator of genes associated with pulmonary fibrosis. | Q35219800 | ||
| Pathological alteration of FoxO3a activity promotes idiopathic pulmonary fibrosis fibroblast proliferation on type i collagen matrix | Q35474548 | ||
| Regulation of the TGFbeta signalling pathway by ubiquitin-mediated degradation | Q35691559 | ||
| Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis | Q35748291 | ||
| Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis | Q35749152 | ||
| Analysing the relationship between lncRNA and protein-coding gene and the role of lncRNA as ceRNA in pulmonary fibrosis | Q35867815 | ||
| Human telomere disease due to disruption of the CCAAT box of the TERC promoter | Q35876974 | ||
| Emerging evidence for endoplasmic reticulum stress in the pathogenesis of idiopathic pulmonary fibrosis | Q35902352 | ||
| Reversal of persistent fibrosis in aging by targeting Nox4-Nrf2 redox imbalance | Q35983620 | ||
| miR-29 inhibits bleomycin-induced pulmonary fibrosis in mice. | Q36014083 | ||
| Transforming growth factor-beta employs HMGA2 to elicit epithelial-mesenchymal transition. | Q36118227 | ||
| Lactic acid is elevated in idiopathic pulmonary fibrosis and induces myofibroblast differentiation via pH-dependent activation of transforming growth factor-β | Q36345223 | ||
| Low expression of long noncoding RNA PANDAR predicts a poor prognosis of non-small cell lung cancer and affects cell apoptosis by regulating Bcl-2. | Q36347290 | ||
| Regulation of mammalian cell differentiation by long non-coding RNAs | Q36382068 | ||
| Viruses and microRNAs | Q36493262 | ||
| Profibrotic role of miR-154 in pulmonary fibrosis | Q36539603 | ||
| MicroRNAs in immune response and macrophage polarization. | Q36547119 | ||
| Principles of micro-RNA production and maturation | Q36617799 | ||
| MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines. | Q36738067 | ||
| Long noncoding RNAs: cellular address codes in development and disease | Q36837377 | ||
| miR-145 regulates myofibroblast differentiation and lung fibrosis | Q36860296 | ||
| Dynamic FoxO transcription factors | Q36889897 | ||
| Multifaceted mammalian transcriptome | Q37158817 | ||
| Lessons from X-chromosome inactivation: long ncRNA as guides and tethers to the epigenome | Q37302890 | ||
| Antitransforming growth factor-beta therapy in fibrosis: recent progress and implications for systemic sclerosis | Q37306427 | ||
| P433 | issue | 18 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell biology | Q7141 |
| pulmonary fibrosis | Q32446 | ||
| P304 | page(s) | 3507-3519 | |
| P577 | publication date | 2015-05-31 | |
| P1433 | published in | Cellular and Molecular Life Sciences | Q5058352 |
| P1476 | title | The code of non-coding RNAs in lung fibrosis | |
| P478 | volume | 72 |
| Q37088324 | MicroRNA-27a-3p Is a Negative Regulator of Lung Fibrosis by Targeting Myofibroblast Differentiation |
| Q45888374 | Potential contribution of alveolar epithelial type I cells to pulmonary fibrosis |
| Q26745905 | Recent advances in understanding idiopathic pulmonary fibrosis |
| Q37080510 | Targeted Therapy for Idiopathic Pulmonary Fibrosis: Where To Now? |
| Q48204626 | The Lung Likes the Little Fella miR-29. |
| Q39382230 | miR-34a Inhibits Lung Fibrosis by Inducing Lung Fibroblast Senescence |
| Q28082698 | ncRNA-regulated immune response and its role in inflammatory lung diseases |
Search more.